These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23327367)

  • 1. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
    Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
    Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of foxe1 variations in papillary thyroid carcinoma.
    Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
    Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
    Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
    Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
    Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
    J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
    Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
    Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
    Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
    Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
    Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.
    Kang J; Deng XZ; Fan YB; Wu B
    Tumour Biol; 2014 Jul; 35(7):7085-96. PubMed ID: 24756757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
    Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
    Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
    He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
    Ding Z; Ke R; Zhang Y; Fan Y; Fan J
    Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Mond M; Bullock M; Yao Y; Clifton-Bligh RJ; Gilfillan C; Fuller PJ
    Thyroid; 2015 Aug; 25(8):904-10. PubMed ID: 25950909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
    Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
    Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
    Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
    Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXE1 association with differentiated thyroid cancer and its progression.
    Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
    Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 19. Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status.
    Paskaš S; Janković J; Marečko I; Išić Denčić T; Tatić S; Cvejić D; Savin S
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):201-9. PubMed ID: 24255086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.
    Mehrazin A; Safarpour H; Davoudi ST; Parsamanesh N; Saeedi F; Miri-Moghaddam E
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2771-2776. PubMed ID: 32986379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.